Blog

Have you ever wondered how risky and dangerous drugs make it to market under the watchful eye of the U.S. Food and Drug Administration, charged with the responsibility of making sure they are safe and effective before they are released? The Journal of the American Medical Association tackles that question […]

It is one of the lesser known transvaginal meshes. Coloplast will now become the sixth multidistrict litigation consolidated and the fifth to be heard in the Southern District of West Virginia. The Judicial Panel on Multidistrict Litigation (JPML) on August 6 ordered at least 24 Coloplast federal lawsuits (MDL No. […]

AstraZeneca has agreed to pay $26 million to settle litigation involving the atypical antipsychotic, Seroquel. The South Carolina Attorney General had been after the company to reimburse state taxpayers for the off-label use of Seroquel. The company, along with other drugmakers, had challenged states that hire product liability attorneys on contingency […]

Imagine having a surgery that’s gone terribly wrong, only to discover – too late – that the doctors used a medical device its manufacturer knew could be dangerous, and worse, one that snuck right past the Food and Drug Administration (FDA). Couldn’t happen in this country? Wrong. More than 1,000 […]

Physicians from American University in Lebanon published a case report regarding Pradaxa (dabigatran etexilate) that was published in the July 28, 2012, edition of the Journal of Thrombosis and Thrombolysis.  In this article, the authors wrote about an 85 year old patient who developed shortness of breath, anemia, and white […]

Virtually all Rejuvenate and ABG II patients have received notice from their doctor that the devices have been recalled. These patients are all now faced with the prospect of a painful and risky revision surgery. Rejuvenate and ABG II victims can basically be placed into three categories. I know. I’ve […]

Johnson & Johnson’s new CEO, Alyx Gorsky, will not be able to avoid having his deposition taken in preparation for the upcoming transvaginal mesh lawsuits pending before a New Jersey Superior Court. The ruling came down July 19, 2012, one day before a landmark ruling in another mesh case in […]

[et_pb_section bb_built=”1″][et_pb_row][et_pb_column type=”4_4″][et_pb_text] Thirteen individuals have sued the makers of Nexium and Prevacid in California state court alleging the drug maker failed to adequately warn doctors and consumers that the acid reflux drugs cause bone loss and osteoporosis. Nexium, manufactured by AstraZeneca, and Prevacid, made by Takeda, are associated with […]

A federal judge has scheduled proceedings for the first of two test trials in the Actos litigation. The bellwether trials, as they are known, are set for November 3, 2014, and January 12, 2015 in the multidistrict litigation consolidated in the U.S. District Court for the Western District of Louisiana. […]

C.R. Bard Inc. must pay a Bakersfield woman $5.5 million in damages in what promises to be the first of thousands of vaginal mesh injury cases to go to trial. Jurors in a Bakersfield, California state court determined July 20th, that the Avaulta Plus Biosynthetic Support System vaginal implant caused […]